SEC Form D private-offering filing
AecorBio Inc.
A new SEC Form D private-offering notice from Menlo Park, CA, a $2,532,988 filer-stated offering target in Biotech. The source filing is one click away.
AecorBio is an IND stage biopharmaceutical company developing peptide therapeutics that target drug resistance mechanisms in oncology, immunology and neurology, with a lead candidate for castration resistant prostate cancer.
Filed 2025-11-12Filed to raise $2,532,988First money in 2025-08-16Raised so far $2,532,988HQ (as filed) Menlo Park, CASector Biotech ✓Stage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified aecorbio.com↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.